A new trading day began on Monday, with Sangamo Therapeutics Inc (NASDAQ: SGMO) stock price down -3.24% from the previous day of trading, before settling in for the closing price of $2.47. SGMO’s price has ranged from $0.30 to $3.18 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 17.84%. Meanwhile, its annual earnings per share averaged 68.33%. With a float of $199.09 million, this company’s outstanding shares have now reached $208.62 million.
Let’s determine the extent of company efficiency that accounts for 405 employees. In terms of profitability, gross margin is 84.55%, operating margin of -256.63%, and the pretax margin is -257.89%.
Sangamo Therapeutics Inc (SGMO) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Sangamo Therapeutics Inc is 4.58%, while institutional ownership is 27.00%.
Sangamo Therapeutics Inc (SGMO) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 68.33% per share during the next fiscal year.
Sangamo Therapeutics Inc (NASDAQ: SGMO) Trading Performance Indicators
Here are Sangamo Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.35. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.54.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.74, a number that is poised to hit -0.09 in the next quarter and is forecasted to reach -0.20 in one year’s time.
Technical Analysis of Sangamo Therapeutics Inc (SGMO)
Looking closely at Sangamo Therapeutics Inc (NASDAQ: SGMO), its last 5-days average volume was 11.84 million, which is a jump from its year-to-date volume of 6.94 million. As of the previous 9 days, the stock’s Stochastic %D was 56.73%. Additionally, its Average True Range was 0.31.
During the past 100 days, Sangamo Therapeutics Inc’s (SGMO) raw stochastic average was set at 69.05%, which indicates a significant increase from 56.73% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 149.62% in the past 14 days, which was higher than the 144.83% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.97, while its 200-day Moving Average is $0.99. However, in the short run, Sangamo Therapeutics Inc’s stock first resistance to watch stands at $2.54. Second resistance stands at $2.69. The third major resistance level sits at $2.79. If the price goes on to break the first support level at $2.29, it is likely to go to the next support level at $2.19. Now, if the price goes above the second support level, the third support stands at $2.04.
Sangamo Therapeutics Inc (NASDAQ: SGMO) Key Stats
With a market capitalization of 498.67 million, the company has a total of 208,647K Shares Outstanding. Currently, annual sales are 176,230 K while annual income is -257,830 K. The company’s previous quarter sales were 49,410 K while its latest quarter income was 10,670 K.
